Active, Not Recruiting
Real-World Joint Outcomes After Selective Transition to Low-Dose Emicizumab in Pediatric Hemophilia A
NCT07439055
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +13 more
- Locations
-
- Chulalongkorn University Bangkok, Thailand